HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

<p>Abstract</p> <p>Background</p> <p>The beneficial effects of early statin use in kidney transplant recipients, especially those on tacrolimus-based immunosuppression, are not well established. We evaluated the predictors of statin use following kidney transplantation...

Full description

Bibliographic Details
Main Authors: Schaefer Heidi, Basu Amit, Tan Henkie, Johnston James, McCauley Jerry, Shapiro Ron, Wu Christine M, Younas Nizar, Smetanka Cynthia, Winkelmayer Wolfgang C, Unruh Mark
Format: Article
Language:English
Published: BMC 2010-04-01
Series:BMC Nephrology
Online Access:http://www.biomedcentral.com/1471-2369/11/5

Internet

http://www.biomedcentral.com/1471-2369/11/5

Similar Items